REGENTIS BIOMATERIALS LTD.

Biotechnology · HERZLIYA, L3

BiotechnologySEC Form D

REGENTIS BIOMATERIALS LTD. filed a Form D with the U.S. Securities and Exchange Commission on June 25, 2026, reporting $6,500,000 raised.

Incorporated in Israel and based in HERZLIYA, L3, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that REGENTIS BIOMATERIALS LTD. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Ehud GellerExecutive Officer · Director
  • Ori GonExecutive Officer
  • Arie GordashnikovExecutive Officer
  • Galit ReskeExecutive Officer
  • Jeff DykanDirector
  • Keith ValentineDirector
  • Efraim Cohen-AraziDirector
  • Pini Ben-ElazarDirector
  • Susan AlpertDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$19.1MRaised

Rapalogix Health, Inc.

BiotechnologyCARLSBAD, CA
Jun 22, 2026View SEC Form D
$150.0KRaised

Chickadee Biomedicines, Inc.

BiotechnologyBOSTON, MA
Jun 22, 2026View SEC Form D
$500.0KRaised

Boston Interactome, Inc.

BiotechnologyALLSTON, MA
Jun 18, 2026View SEC Form D
$3.8MRaised

DINYA DNA, Inc.

BiotechnologyOAKLAND, CA
Jun 18, 2026View SEC Form D
$16.5MRaised

IceCure Medical Ltd.

BiotechnologyCAESAREA, L3
Jun 17, 2026View SEC Form D